# Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women

> **NCT01527825** · PHASE3 · COMPLETED · sponsor: **University of Witwatersrand, South Africa** · enrollment: 800 (actual)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Trivalent influenza vaccine (seasonal)
- **BIOLOGICAL:** Normal saline

## Key facts

- **NCT ID:** NCT01527825
- **Lead sponsor:** University of Witwatersrand, South Africa
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 800 (ACTUAL)
- **Last updated:** 2015-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01527825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01527825, "Immunogenicity and Safety of Different Dosing Schedules of Trivalent Influenza Vaccine in HIV-infected Pregnant Women". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01527825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*